| http://www.w3.org/ns/prov#value | - However, in a trial specifically designed to demonstrate equivalency of 2 therapeutic options (in which a negative result is anticipated) a smaller ?? (or larger power) is desired since avoiding a type II error in this setting is particularly important.5,6 In our study, we set the power at .80, which is the minimally acceptable level, especially for trials that claim equivalency.
|
